The DKC1 inhibitor pyrazofuran and the MEK1/2 inhibitor trametinib synergistically inhibit CRC growth.496 Studies also found a cancer-specific single nucleotide variant at nucleotide 1248.U in 18S rRNA from CRC patients. Here, DKC1 is linked to cancer.